Skip to content
Dx

ICD-10-CM 2027 diagnosis code

C49.0Malignant neoplasm of connective and soft tissue of head, face and neck

✓ Billable / specificCC — complication/comorbidity

C49.0 is a valid, billable ICD-10-CM code for malignant neoplasm of connective and soft tissue of head, face and neck. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Malig neoplm of conn and soft tissue of head, face and neck

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About C49.0

C49.0 is the ICD-10-CM diagnosis code for malignant neoplasm of connective and soft tissue of head, face and neck. It belongs to category C49 (malignant neoplasm of other connective and soft tissue), block C45-C49 (malignant neoplasms of mesothelial and soft tissue) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within C49 (malignant neoplasm of other connective and soft tissue), C49.0 is specifically for malignant neoplasm of connective and soft tissue of head, face and neck. Related codes cover malignant neoplasm of connective and soft tissue of upper limb, including shoulder (C49.1), malignant neoplasm of connective and soft tissue of lower limb, including hip (C49.2), malignant neoplasm of connective and soft tissue of thorax (C49.3), malignant neoplasm of connective and soft tissue of abdomen (C49.4), malignant neoplasm of connective and soft tissue of pelvis (C49.5), malignant neoplasm of connective and soft tissue of trunk, unspecified (C49.6), malignant neoplasm of overlapping sites of connective and soft tissue (C49.8), malignant neoplasm of connective and soft tissue, unspecified (C49.9) and 1 more.

Don't report C49.0 together with the conditions in its Excludes1 note: connective tissue of orbit (C69.6-).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 542 (Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy with MCC, relative weight 1.7211), DRG 543 (Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy with CC, relative weight 1.006) and DRG 544 (Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy without CC/MCC, relative weight 0.7406), in MDC 08 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 171.0 (malignant neoplasm of connective and other soft tissue of head, face, and neck).

Coding notes

Applicable toConditions and synonyms classified to this code
  • Malignant neoplasm of connective tissue of ear
  • Malignant neoplasm of connective tissue of eyelid
Excludes1Not coded here — never report together with this code
  • connective tissue of orbit (C69.6-)

Notes that apply from higher levels

Instructions written at a parent level also apply to C49.0.

› From C49 Malignant neoplasm of other connective and soft tissue
Includes
  • malignant neoplasm of blood vessel
  • malignant neoplasm of bursa
  • malignant neoplasm of cartilage
  • malignant neoplasm of fascia
  • malignant neoplasm of fat
  • malignant neoplasm of ligament, except uterine
  • malignant neoplasm of lymphatic vessel
  • malignant neoplasm of muscle
  • malignant neoplasm of synovia
  • malignant neoplasm of tendon (sheath)
Excludes1
  • malignant neoplasm of cartilage (of):
  • articular (C40-C41)
  • larynx (C32.3)
  • nose (C30.0)
  • malignant neoplasm of connective tissue of breast (C50.-)
Excludes2
  • Kaposi's sarcoma of soft tissue (C46.1)
  • malignant neoplasm of heart (C38.0)
  • malignant neoplasm of peripheral nerves and autonomic nervous system (C47.-)
  • malignant neoplasm of peritoneum (C48.2)
  • malignant neoplasm of retroperitoneum (C48.0)
  • malignant neoplasm of uterine ligament (C57.3)
  • mesothelioma (C45.-)

Broader instructions also apply from Chapter 2: Neoplasms.

Table of Drugs & Neoplasms entries

Codes whose notes reference C49.0

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 171.0Malignant neoplasm of connective and other soft tissue of head, face, and neckapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about C49.0

Is C49.0 billable?

Yes. C49.0 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can C49.0 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict C49.0 as a principal diagnosis.

Is C49.0 a CC or MCC?

C49.0 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.

What DRG does C49.0 group to?

C49.0 is used in the MS-DRG v44.0 logic for MS-DRG 542 (Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy with MCC), MS-DRG 543 (Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy with CC) and MS-DRG 544 (Pathological Fractures and Musculoskeletal and Connective Tissue Malignancy without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for C49.0?

The CMS General Equivalence Mappings map C49.0 to ICD-9-CM 171.0.